Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Alina Alshevskaya"'
Publikováno v:
Biomedicines, Vol 12, Iss 3, p 699 (2024)
Immunotherapy using dendritic cell-based vaccination is a natural approach using the capabilities and functions inherent in the patient’s immune system to eliminate tumor cells. The development of dendritic cell-based cell technologies evolved as t
Externí odkaz:
https://doaj.org/article/1ad7378b3f544ea499bccbbf5663117e
Autor:
Ekaterina Alexeeva, Gerd Horneff, Tatyana Dvoryakovskaya, Rina Denisova, Irina Nikishina, Elena Zholobova, Viktor Malievskiy, Galina Santalova, Elena Stadler, Larisa Balykova, Yuriy Spivakovskiy, Ivan Kriulin, Alina Alshevskaya, Andrey Moskalev
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 19, Iss 1, Pp 1-12 (2021)
Abstract Background Remission is the primary objective of treating juvenile idiopathic arthritis (JIA). It is still debatable whether early intensive treatment is superior in terms of earlier achievement of remission. The aim of this study was to eva
Externí odkaz:
https://doaj.org/article/cd62454768b8421c8062c6a0baa2b769
Autor:
Alina Alshevskaya, Julia Lopatnikova, Julia Zhukova, Oksana Chumasova, Nadezhda Shkaruba, Alexey Sizikov, Irina Evsegneeva, Daria Demina, Vera Nepomniashchikch, Aleksander Karaulov, Sergey Sennikov
Publikováno v:
Cells, Vol 12, Iss 1, p 5 (2022)
One of the mechanisms of cellular dysfunction during the chronization of immune-system-mediated inflammatory diseases is a change in the profile of expression and co-expression of receptors on cells. The aim of this study was to compare patterns of r
Externí odkaz:
https://doaj.org/article/843011a1f51e4638819756527a09f17a
Autor:
Ekaterina Alexeeva, Tatyana Dvoryakovskaya, Rina Denisova, Tatyana Sleptsova, Kseniya Isaeva, Alexandra Chomahidze, Anna Fetisova, Anna Mamutova, Alina Alshevskaya, Victor Gladkikh, Andrey Moskalev
Publikováno v:
Pediatrics and Neonatology, Vol 60, Iss 5, Pp 549-555 (2019)
Background: Both the steroid- and NSAID-sparing effects of biologics in juvenile idiopathic arthritis (JIA) treatment are key aspects of the dynamics of patient’s condition. The proper selection of biologics enables maximum treatment effectiveness
Externí odkaz:
https://doaj.org/article/d6663ef927814cb4a36a31502d1e630e
Autor:
Alina Alshevskaya, Julia Zhukova, Fedor Kireev, Julia Lopatnikova, Irina Evsegneeva, Daria Demina, Vera Nepomniashchikch, Victor Gladkikh, Alexander Karaulov, Sergey Sennikov
Publikováno v:
Cells, Vol 11, Iss 11, p 1736 (2022)
Background: The co-expression patterns of type 1 and 2 tumor necrosis factor (TNF)-α membrane receptors (TNFR1/TNFR2) are associated with the presence, stage, and activity of allergic diseases. The aim of this study was to assess the expression leve
Externí odkaz:
https://doaj.org/article/3f9495d99fea498db97d2a615051e7b7
Autor:
Igor Zhirov, Natalia Safronova, Yulia Osmolovskaya, Alina Alshevskaya, Andrey Moskalev, Sergey Tereshchenko
Publikováno v:
Cardiology Research and Practice, Vol 2019 (2019)
Background. Atrial fibrillation (AF) and heart failure (HF) are tightly interrelated. The concurrence of these pathologies can aggravate the pathological process. The geographic and ethnic characteristics of patients may significantly affect the effi
Externí odkaz:
https://doaj.org/article/932b1e91a5f44fe4a4cb5f4584d14e3c
Publikováno v:
Immunologiya. 43:632-642
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d75011b4eb5d4b9da3460f79198bb34
https://doi.org/10.33029/0206-4952-2022-43-6-632-642
https://doi.org/10.33029/0206-4952-2022-43-6-632-642
Autor:
Olga Perik-Zavodskaia, Julia Zhukova, Roman Perik-Zavodskii, Alina Alshevskaya, Julia Lopatnikova, Sergey Sennikov
Publikováno v:
Genes. 14:1074
Alternative splicing is a part of mRNA processing that expands the diversity of proteins encoded by a single gene. Studying the full range of proteins–products of translation of alternatively spliced mRNA is extremely important for understanding th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3c9906ca18671d4eb6b6dfb3cb6993a
https://doi.org/10.3390/genes14051074
https://doi.org/10.3390/genes14051074
Autor:
Rina Denisova, T. Dvoryakovskaya, Alexandra Chomahidze, A. Fetisova, Alina Alshevskaya, A. Mamutova, Ekaterina Alexeeva, T. Sleptsova, Andrey Moskalev, K. Isaeva
Publikováno v:
Egyptian Rheumatologist, Vol 42, Iss 3, Pp 231-236 (2020)
Background New biologics developed to treat juvenile idiopathic arthritis (JIA) and the broadening range of indications for young children offer new drug switch options if the first-line treatment has proved ineffective. Nevertheless, the question re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e8d6f20800f79a26be3113ba41efd69
http://www.sciencedirect.com/science/article/pii/S111011642030034X
http://www.sciencedirect.com/science/article/pii/S111011642030034X
Autor:
A. Fetisova, T. Dvoryakovskaya, Alexandra Chomahidze, Rina Denisova, Alina Alshevskaya, T. Sleptsova, K. Isaeva, Victor Gladkikh, Andrey Moskalev, A. Mamutova, Ekaterina Alexeeva
Publikováno v:
Pediatrics and Neonatology, Vol 60, Iss 5, Pp 549-555 (2019)
Background: Both the steroid- and NSAID-sparing effects of biologics in juvenile idiopathic arthritis (JIA) treatment are key aspects of the dynamics of patient’s condition. The proper selection of biologics enables maximum treatment effectiveness
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aea2689c87db3e268eb9b4f0026fc006
https://doi.org/10.1016/j.pedneo.2019.02.003
https://doi.org/10.1016/j.pedneo.2019.02.003